The Pulmonary-Alveolar Macrophage

New England Journal of Medicine

Volumn 301, Issue 11, 1979, Pages 580-587

  Hocking, William G ^a   Golde, David W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG ALVEOLUS MACROPHAGE; NORMAL HUMAN; PHAGOCYTOSIS; RESPIRATORY SYSTEM; SHORT SURVEY;

ANIMAL; ANTIBODIES, BACTERIAL; BACTERIA; BINDING SITES, ANTIBODY; CYTOPLASMIC GRANULES; FEMALE; HUMAN; IMMUNOGLOBULIN G; INFECTION; KINETICS; LUNG DISEASES; MACROPHAGES; MALE; MICE; PHAGOCYTOSIS; PULMONARY ALVEOLI; RABBITS; RATS; SMOKING; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0018711383     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197909133011104     Document Type: Review

References (110)

1. Cohen AB, Gold WM: Defense mechanisms of the lungs. Annu Rev Physiol 37: 325–350, 1975
2. Green GM, Kass EH: The role of the alveolar macrophage in the clearance of bacteria from the lung. J Exp Med 119: 167–175, 1964
3. Myrvik QN, Leake ES, Fariss B: Studies on pulmonary alveolar macrophages from the normal rabbit: a technique to procure them in a high state of purity. J Immunol 86: 128–132, 1961
4. Finley TN, Swenson EW, Curran WS, et al: Bronchopulmonary lavage in normal subjects and patients with obstructive lung disease. Ann Intern Med 66: 651–658, 1967
5. Simon LM, Robin ED, Phillips JR, et al: Enzymatic basis for bioenergetic differences of alveolar versus peritoneal macrophages and enzyme regulation by molecular O2. J Clin Invest 59: 443–448, 1977
6. Golde DW, Drew WL, Klein HZ, et al: Occult pulmonary haemorrhage in leukaemia. Br Med J 2: 166–168, 1975
7. van Furth R: Origin and kinetics of monocytes and macrophages. Semin Hematol 7: 125–141, 1970
8. Volkman A, Gowans JL: The origin of macrophages from bone marrow in the rat. Br J Exp Pathol 46: 62–70, 1965
9. Brunstetter M-A, Hardie JA, Schiff R, et al: The origin of pulmonary alveolar macrophages: studies of stem cells using the Es-2 marker of mice. Arch Intern Med 127: 1064–1068, 1971
10. Weiden PL, Storb R, Tsoi M-S: Marrow origin of canine alveolar macrophages. J Reticuloendothel Soc 17: 342–345, 1975
11. Godleski JJ, Brain JD: The origin of alveolar macrophages in mouse radiation chimeras. J Exp Med 136: 630–643, 1972
12. Shand FL, Bell EB: Studies on the distribution of macrophages derived from rat bone marrow cells in xenogeneic radiation chimaeras. Immunology 22: 549–556, 1972
13. Pinkett MO, Cowdrey CR, Nowell PC: Mixed hematopoietic and pulmonary origin of'alveolar macrophages’ as demonstrated by chromosome markers. Am J Pathol 48: 859–867, 1966
14. Virolainen M: Hematopoietic origin of macrophages as studied by chromosome markers in mice. J Exp Med 127: 943–952, 1968
15. Bowden DH, Adamson IYR, Grantham WG, et al: Origin of the lung macrophage: evidence derived from radiation injury. Arch Pathol 88: 540–546, 1969
16. Bowden DH, Adamson IYR: The pulmonary interstitial cell as immediate precursor of the alveolar macrophage. Am J Pathol 68: 521–528, 1972
17. Soderland SC, Naum Y: Growth of pulmonary alveolar macrophages in vitro. Nature 245: 150–152, 1973
18. Naum Y: Growth of pulmonary alveolar macrophages in vitro: responses to media conditioned by lung cell lines. Cytobios 14: 211–220, 1975
19. Evans MJ, Cabrai LJ, Stephens RJ, et al: Cell division of alveolar macrophages in rat lung following exposure to NO2. Am J Pathol 70: 199–206, 1973
20. Lin H-S, Kuhn C, Kuo T-T: Clonal growth of hamster free alveolar cells in soft agar. J Exp Med 142: 877–886, 1975
21. Golde DW: Kinetics and function of the human alveolar macrophage. J Reticuloendothel Soc 22: 223–230, 1977
22. Thomas ED, Ramberg RE, Sale GE, et al: Direct evidence for a bone marrow origin of the alveolar macrophage in man. Science 192: 1016–1018, 1976
23. Golde DW, Byers LA, Finley TN: Proliferative capacity of human alveolar macrophage. Nature 247: 373–375, 1974
24. Golde DW, Finley TN, Cline MJ: The pulmonary macrophage in acute leukemia. N Engl J Med 290: 875–878, 1974
25. Bertalanffy FD: Respiratory tissue: structure, histophysiology, cytodynamics. I. Review and basic cytomorphology. Int Rev Cytol 16: 233–328, 1964
26. Golde DW, Burgaleta C, Sparkes RS, et al: The Philadelphia chromosome in human macrophages. Blood 49: 367–370, 1977
27. Fialkow PJ, Jacobson RJ, Papayannopoulou T: Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med 63: 125–130, 1977
28. Weibel ER, Gil J: Electron microscopic demonstration of an extracellular duplex lining layer of alveoli. Respir Physiol 4: 42–57, 1968
29. Mann PEG, Cohen AB, Finley TN, et al: Alveolar macrophages: structural and functional differences between nonsmokers and smokers of marijuana and tobacco. Lab Invest 25: 111–120, 1971
30. Pratt SA, Smith MH, Ladman AJ, et al: The ultrastructure of alveolar macrophages from human cigarette smokers and nonsmokers. Lab Invest 24: 331–338, 1971
31. Cohen AB, Cline MJ: The human alveolar macrophage: isolation, cultivation in vitro, and studies of morphologic and functional characteristics. J Clin Invest 50: 1390–1398, 1971
32. Harris JO, Swenson EW, Johnson JE III: Human alveolar macrophages: comparison of phagocytic ability, glucose utilization, and ultrastructure in smokers and nonsmokers. J Clin Invest 49: 2086–2096, 1970
33. Cohn ZA, Wiener E: The particulate hydrolases of macrophages. I. Comparative enzymology, isolation, and properties. J Exp Med 118: 991–1008, 1963
34. Sorber WA, Leake ES, Myrvik QN: Isolation and characterization of hydrolase-containing granules from rabbit lung macrophages. J Reticuloendothel Soc 16: 184–192, 1974
35. Yarborough DJ, Meyer OT, Dannenberg AM Jr, et al: Histochemistry of macrophage hydrolases. III. Studies on β-galactosidase, β-glucuronidase and aminopeptidase with indolyl and naphthyl substrates. J Reticuloendothel Soc 4: 390–408, 1967
36. Stossel TP, Mason RJ, Pollard TD, et al: Isolation and properties of phagocytic vesicles. II. Alveolar macrophages. J Clin Invest 51: 604–614, 1972
37. Nichols BA: Normal rabbit alveolar macrophages. II. Their primary and secondary lysosomes as revealed by electron microscopy and cytochemistry. J Exp Med 144: 920–932, 1976
38. Franson RC, Waite M: Lysosomal phospholipases A1 and A2 of normal and bacillus Calmette Guérin-induced alveolar macrophages. J Cell Biol 56: 621–627, 1973
39. Weissmann G: The role of lysosomes in inflammation and disease. Annu Rev Med 18: 97–112, 1967
40. Cohn ZA, Wiener E: The particulate hydrolases of macrophages. II. Biochemical and morphological response to particle ingestion. J Exp Med 118: 1009–1020, 1963
41. Nichols BA: Normal rabbit alveolar macrophages. I. The phagocytosis of tubular myelin. J Exp Med 144: 906–919, 1976
42. Myrvik QN, Leake ES, Fariss B: Lysozyme content of alveolar and peritoneal macrophages from the rabbit. J Immunol 86: 133–136, 1961
43. Leake ES, Gonzalez-Ojeda D, Myrvik QN: Enzymatic differences between normal alveolar macrophages and oil-induced peritoneal macrophages obtained from rabbits. Exp Cell Res 33: 553–561, 1964
44. Pratt SA, Finley TN, Smith MH, et al: A comparison of alveolar macrophages and pulmonary surfactant(?) obtained from the lungs of human smokers and nonsmokers by endobronchial lavage. Anat Rec 163: 497–508, 1969
45. Martin RR: Altered morphology and increased acid hydrolase content of pulmonary macrophages from cigarette smokers. Am Rev Respir Dis 107: 596–601, 1973
46. Brody AR, Craighead JE: Cytoplasmic inclusions in pulmonary macrophages of cigarette smokers. Lab Invest 32: 125–132, 1975
47. Quan SG, Golde DW: Surface morphology of the human alveolar macrophage. Exp Cell Res 109: 71–77, 1977
48. Oren R, Farnham AE, Saito K, et al: Metabolic patterns in three types of phagocytizing cells. J Cell Biol 17: 487–501, 1963
49. Sbarra AJ, Karnovsky ML: The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes. J Biol Chem 234: 1355–1362, 1959
50. Katz J, Wood HG: The use of C14O2 yields from glucose-1- and -6-C14 for the evaluation of the pathways of glucose metabolism. J Biol Chem 238: 517–523, 1963
51. Ouchi E, Selvaraj RJ, Sbarra AJ: The biochemical activities of rabbit alveolar macrophages during phagocytosis. Exp Cell Res 40: 456–468, 1965
52. Mason RJ, Stossel TP, Vaughan M: Quantitative studies of phacogytosis by alveolar macrophages. Biochim Biophys Acta 304: 864–870, 1973
53. Cohen HJ, Chovaniec ME: Superoxide production by digitonin-stimulated guinea pig granulocytes: the effects of N-ethyl maleimide, divalent cations, and glycolytic and mitochondrial inhibitors on the activation of the Superoxide generating system. J Clin Invest 61: 1088–1096, 1978
54. Stossel TP: Phagocytosis: recognition and ingestion. Semin Hematol 12: 83–116, 1975
55. Klebanoff SJ: Antimicrobial mechanisms in neutrophilic polymorphonuclear leukocytes. Semin Hematol 12: 117–142, 1975
56. Rowlands DT Jr, Daniele RP: Surface receptors in the immune response. N Engl J Med 293: 26–32, 1975
57. Mantovani B, Rabinovitch M, Nussenzweig V: Phagocytosis of immune complexes by macrophages. Different roles of the macrophage receptor sites for complement (C3) and for immunoglobulin (IgG). J Exp Med 135: 780–792, 1972
58. Reynolds HY, Atkinson JP, Newball HH, et al: Receptors for immunoglobulin and complement on human alveolar macrophages. J Immunol 114: 1813–1819, 1975
59. Daughaday CC, Douglas SD: Membrane receptors on rabbit and human pulmonary alveolar macrophages. J Reticuloendothel Soc 19: 37–45, 1976
60. Shurin SB, Stossel TP: Complement (C3)-activated phagocytosis by lung macrophages. J Immunol 120: 1305–1312, 1978
61. Arend WP, Mannik M: The macrophage receptor for IgG: number and affinity of binding sites. J Immunol 110: 1455–1463, 1973
62. Montarroso AM, Myrvik QN: Effect of BCG vaccination on the IgG and complement receptors on rabbit alveolar macrophages. J Reticuloendothel Soc 24: 93–99, 1978
63. Stossel TP: The mechanism of phagocytosis. J Reticuloendothel Soc 19: 237–245, 1976
64. Reaven EP, Axline SG: Subplasmalemmal microfilaments and microtubules in resting and phagocytizing cultivated macrophages. J Cell Biol 59: 12–27, 1973
65. Stossel TP, Hartwig JH: Interactions of actin, myosin, and a new actin-binding protein of rabbit pulmonary macrophages. II. Role in cytoplasmic movement and phagocytosis. J Cell Biol 68: 602–619, 1976
66. Hartwig JH, Stossel TP: Isolation and properties of actin, myosin, and a new actin-binding protein in rabbit alveolar macrophages. J Biol Chem 250: 5696–5705, 1975
67. Stossel TP, Hartwig JH: Interactions between actin, myosin, and an actin-binding protein from rabbit alveolar macrophages: alveolar macrophage myosin MG:2+-adenosine triphosphatase requires a cofactor for activation by actin. J Biol Chem 250: 5706–5712, 1975
68. Gee JBL, Vassallo CL, Bell P, et al: Catalase-dependent peroxidative metabolism in the alveolar macrophage during phagocytosis. J Clin Invest 49: 1280–1287, 1970
69. Klebanoff SJ, Hamon CB: Antimicrobial systems of mononuclear phagocytes, Mononuclear Phagocytes in Immunity, Infection, and Pathology. Edited by R van Furth. Oxford, Blackwell Scientific Publications, 1973, pp 507–531
70. Boxer LA, Ismail G, Allen JM, et al: Oxidative metabolic responses of rabbit pulmonary alveolar macrophages. Blood 53: 486–491, 1979
71. Vogt MT, Thomas C, Vassallo CL, et al: Glutathione-dependent peroxidative metabolism in the alveolar macrophage. J Clin Invest 50: 401–410, 1971
72. Rossi F, Zabucchi G, Romeo D: Metabolism of phagocytosing mononuclear phagocytes, Mononuclear Phagocytes in Immunity, Infection, and Pathology. Edited by R van Furth. Oxford, Blackwell Scientific Publications, 1973, pp 441–462
73. Klebanoff SJ, Hamon CB: Role of myeloperoxidase-mediated antimicrobial systems in intact leukocytes. J Reticuloendothel Soc 12: 170–196, 1972
74. Biggar WD, Sturgess JM: Peroxidase activity of alveolar macrophages. Lab Invest 34: 31–42, 1976
75. van Furth R, Hirsch JG, Fedorko ME: Morphology and peroxidase cytochemistry of mouse promonocytes, monocytes, and macrophages. J Exp Med 132: 794–805, 1970
76. Romeo D, Cramer R, Marzi T, et al: Peroxidase activity of alveolar and peritoneal macrophages. J Reticuloendothel Soc 13: 399–409, 1973
77. Paul BB, Strauss RR, Selvaraj RJ, et al: Peroxidase mediated antimicrobial activities of alveolar macrophage granules. Science 181: 849–850, 1973
78. Davis GS, Mortara M, Pfeiffer LM, et al: Bactericidal and biochemical peroxidase activity in human alveolar macrophages. Am Rev Respir Dis 115: Suppl: 210, 1977
79. Biggar WD, Buron S, Holmes B: Bactericidal mechanisms in rabbit alveolar macrophages: evidence against peroxidase and hydrogen peroxide bactericidal mechanisms. Infect Immun 14: 6–10, 1976
80. Klebanoff SJ: Antimicrobial activity of catalase at acid pH. Proc Soc Exp Biol Med 132: 571–574, 1969
81. Lehrer RI, Cline MJ: Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection. J Clin Invest 48: 1478–1488, 1969
82. Lehrer RI: The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms. J Clin Invest 55: 338–346, 1975
83. Golde DW, Territo M, Finley TN, et al: Defective lung macrophages in pulmonary alveolar proteinosis. Ann Intern Med 85: 304–309, 1976
84. Babior BM, Kipnes RS, Curnutte JT: Biological defense mechanisms: the production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 52: 741–744, 1973
85. Gee JBL, Khandwala AS: Oxygen metabolism in the alveolar macrophage: friend or foe? J Reticuloendothel Soc 19: 229–236, 1976
86. Drath DB, Karnovsky ML: Superoxide production by phagocytic leukocytes. J Exp Med 141: 257–262, 1975
87. Johnson GS, Rister M, Higgins C, et al: A comparative study of superoxide dismutase activity in polymorphonuclear leukocytes and alveolar macrophages in humans and guinea pigs. Clin Res 24: 346A, 1976
88. Zeya HI, Spitznagel JK: Arginine-rich proteins of polymorphonuclear leukocyte lysosomes: antimicrobial specificity and biochemical heterogeneity. J Exp Med 127: 927–941, 1968
89. Lehrer RI, Ferrari LG, Patterson-Delafield J: The fungicidal activity of rabbit macrophages. Clin Res 25: 490A, 1977
90. Jay SJ, Johanson WG Jr, Pierce AK, et al: Determinants of lung bacterial clearance in normal mice. J Clin Invest 57: 811–817, 1976
91. Goldstein E, Lippert W, Warshauer D: Pulmonary alveolar macrophage: defender against bacterial infection of the lung. J Clin Invest 54: 519–528, 1974
92. Kim M, Goldstein E, Lewis JP, et al: Murine pulmonary alveolar macrophages: rates of bacterial ingestion, inactivation, and destruction. J Infect Dis 133: 310–319, 1976
93. Kass EH, Green GM, Goldstein E: Mechanisms of antibacterial action in the respiratory system. Bacteriol Rev 30: 488–497, 1966
94. Reynolds HY, Thompson RE: Pulmonary host defenses. II. Interaction of respiratory antibodies with Pseudomonas aeruginosa and alveolar macrophages. J Immunol 111: 369–380, 1973
95. Reynolds HY, Kazmierowski JA, Newball HH: Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages. J Clin Invest 56: 376–385, 1975
96. Skornik WA, Dressler DP: Alveolar macrophage function in immunized, burned rats. Arch Surg 108: 715–719, 1974
97. LaForce FM: Effect of aerosol immunization with RE 595 Salmonella minnesota on lung bactericidal activity against Serratia marcescens, Enterobacter cloacae, and Pseudomonas aeruginosa. Am Rev Respir Dis 116: 241–249, 1977
98. Jakab GJ, Green GM: The effect of Sendai virus infection on bactericidal and transport mechanisms of the murine lung. J Clin Invest 51: 1989–1998, 1972
99. Warshauer D, Goldstein E, Akers T, et al: Effect of influenza viral infection on the ingestion and killing of bacteria by alveolar macrophages. Am Rev Respir Dis 115: 269–277, 1977
100. Jakab GJ, Green GM: Immune enhancement of pulmonary bactericidal activity in murine virus pneumonia. J Clin Invest 52: 2878–2884, 1973
101. Austrian R, Douglas RM, Schiffman G, et al: Prevention of pneumococcal pneumonia by vaccination. Trans Assoc Am Physicians 89: 184–194, 1976
102. Juers JA, Rogers RM, McCurdy JB, et al: Enhancement of bactericidal capacity of alveolar macrophages by human alveolar lining material. J Clin Invest 58: 271–275, 1976
103. LaForce FM, Kelly WJ, Huber GL: Inactivation of staphylococci by alveolar macrophages with preliminary observations on the importance of alveolar lining material. Am Rev Respir Dis 108: 784–790, 1973
104. Mason RJ, Stossel TP, Vaughan M: Lipids of alveolar macrophages, polymorphonuclear leukocytes, and their phagocytic vesicles. J Clin Invest 51: 2399–2407, 1972
105. Goldstein E, Green GM: The effect of acute renal failure on the bacterial clearance mechanisms of the lung. J Lab Clin Med 68: 531–542, 1966
106. Goldstein E, Green GM, Seamans C: The effect of acidosis on pulmonary bactericidal function. J Lab Clin Med 75: 912–923, 1970
107. Guarneri JJ, Laurenzi GA: Effect of alcohol on the mobilization of alveolar macrophages. J Lab Clin Med 72: 40–51, 1968
108. Green GM, Kass EH: Factors influencing the clearance of bacteria by the lung. J Clin Invest 43: 769–776, 1964
109. Hahn FF, Goldstein E, Dungworth DL: Effect of whole-body X-irradiation on pulmonary bactericidal function. Radiat Res 47: 461–471, 1971
110. Hunninghake GW, Fauci AS: Immunologic reactivity of the lung. III. Effects of corticosteroids on alveolar macrophage cytotoxic effector cell function. J Immunol 118: 146–150, 1977